MedPage Today on MSN
What a U.S. Study Found About the Shingles Vaccine and Dementia
Analysis assessed dementia risk with the current two-dose shot ...
Researchers estimate that during their lifetime, one out of every three people will develop shingles — a viral condition causing an extremely painful rash that eventually blisters. Since 2006, older ...
The shingles vaccine helps slow the progress of dementia, a new study suggests. The research, published Tuesday, adds to a growing body of evidence that getting vaccinated against shingles offers ...
Among older adults who received at least one dose of the recombinant shingles vaccine, vaccine effectiveness against any herpes zoster-related outcome was 56.1%. Getting a second dose yielded a ...
The shingles vaccine is intended to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, also known as herpes zoster, but a new study suggests that it could have ...
New research shows that the shingles vaccine not only reduces inflammation but may also slow the aging process. Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...
When a person thinks of aging, they normally think of their chronological age and how many birthdays they’ve had so far. Over the last few years, there has been more talk about how people can slow ...
The shingles vaccine can significantly reduce the chance of developing vascular dementia, while also lowering the risk of blood clots, heart attacks and death in people ages 50 and older, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results